Human Metabolome Technologies Inc
TSE:6090

Watchlist Manager
Human Metabolome Technologies Inc Logo
Human Metabolome Technologies Inc
TSE:6090
Watchlist
Price: 698 JPY Market Closed
Market Cap: ¥4.1B

Operating Margin

11.9%
Current
Declining
by 4.2%
vs 3-y average of 16.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.9%
=
Operating Income
¥163.4m
/
Revenue
¥1.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.9%
=
Operating Income
¥163.4m
/
Revenue
¥1.4B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Human Metabolome Technologies Inc
TSE:6090
4B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.4B USD
Loading...
US
Danaher Corp
NYSE:DHR
166B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.1B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
277.8B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.6T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Higher than 75% of companies in Japan
Percentile
75th
Based on 6 730 companies
75th percentile
11.9%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Human Metabolome Technologies Inc
Glance View

Human Metabolome Technologies, Inc. engages in the business of diagnostic technology and medical products. The company is headquartered in Tsuruoka-Shi, Yamagata-Ken and currently employs 69 full-time employees. The company went IPO on 2013-12-24. The firm operates in two segments. The Metabolome Analysis segment engages in the provision of analysis service that analyzes metabolomics of measurement samples and reports the results to customers. The Biomarker segment is engaged in the exploration of biomarkers, and the research and development of in vitro diagnostic drugs and diagnostic equipment.

Intrinsic Value
616.4 JPY
Overvaluation 12%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11.9%
=
Operating Income
¥163.4m
/
Revenue
¥1.4B
What is Human Metabolome Technologies Inc's current Operating Margin?

The current Operating Margin for Human Metabolome Technologies Inc is 11.9%, which is below its 3-year median of 16.1%.

How has Operating Margin changed over time?

Over the last 3 years, Human Metabolome Technologies Inc’s Operating Margin has decreased from 18.3% to 11.9%. During this period, it reached a low of 11.9% on Oct 30, 2025 and a high of 21.5% on Mar 31, 2025.

Back to Top